This $3M Healthcare / Medical Pays $890,942/Year After Debt

Priced at or below the benchmark multiple and coverage clears the 2.0x Bulletproof threshold. The margin runs well above the benchmark, which is the part to verify first.

This is a healthcare / medical business listed at $3M, generating $1.8M in annual revenue and $1.3M in seller's discretionary earnings. At a 2.22x cash flow multiple, the asking price is within the 3.00x Bulletproof threshold and below the 3.00x benchmark for healthcare / medical businesses. The profit margin is 74%, well above the 19% benchmark for healthcare / medical businesses, about 3.9x the category figure.

We ran this deal through the DealScore Pro Bulletproof Calculator to see how it holds up across all five scoring criteria. Here is the full breakdown.

Deal Snapshot

Key Metrics
Industry
Healthcare / Medical
Asking Price
$3M
Revenue
$1.8M
Cash Flow (SDE)
$1.3M
Cash Flow Multiple
2.22x
Industry avg: 3.00x
Profit Margin
74%
Industry avg: 19%

The deal snapshot tells a clean story. Revenue of $1.8M produces a 74% margin, well above the 19% benchmark for healthcare / medical businesses, about 3.9x the category figure. The 2.22x multiple is within the 3.00x Bulletproof threshold and below the 3.00x benchmark for healthcare / medical businesses.

Financing Overview

Using the standard 80/10/10 SBA deal structure (80% SBA 7(a) loan, 10% seller financing, 10% buyer down payment), here is what this acquisition looks like when financed.

SBA Financing Breakdown
Total Acquisition Cost
$3.2M
Purchase price plus SBA guaranty fee and closing costs. The three financing slices below are shares of the purchase price only.
Down Payment
$299,900
SBA Loan
$2.4M
10-year term, ~10.5% rate
Seller Note
$299,900
Typically 2-year standby, then 5-year amort
Cash Required at Closing
$596,308
Down payment plus $89,970 closing costs plus $206,438 working capital reserve
Annual Debt Service
$458,058
Post-Debt Cash FlowBefore replacing the owner’s role
$890,942 / year
DSCR
2.95x
Bulletproof minimum: 2.0x
Stress Test (20% Revenue Drop)
Passes
Still covers debt at $1.5M revenue

Why the Numbers Matter

The headline number most buyers fixate on is the asking price. But the asking price alone tells you almost nothing about whether a deal is worth doing. What matters is what happens after you finance it.

The post-debt cash flow of $890,942 per year is what is left after every loan payment on the figures entered. On a $299,900 cash investment, that is a strong return, and it is well above the $100K minimum threshold that the Bulletproof standard requires. This figure is calculated before any cost of replacing the owner’s own role in the business. Where the seller is also the person producing the revenue, a buyer should subtract what it would cost to hire that role before treating this as take-home pay.

The DSCR of 2.95x means the business generates $2.95 for every $1 of annual debt payment. SBA lenders require a minimum of 1.25x. The Bulletproof standard requires 2.0x. This deal clears both with room to spare, which means you have a real safety margin if revenue softens or costs spike unexpectedly.

The stress test is where many deals that look good on paper fall apart. We model a 20% drop in revenue and check whether the business can still cover all debt obligations. This deal passes. Even at $1.5M in revenue (down from $1.8M), the cash flow still services the debt. That is the kind of resilience you want in a financed acquisition.

Industry Context

📈 How This Deal Compares to the Healthcare / Medical Industry

Healthcare / Medical carries an SBA default rate of 2.8%, below the 5.1% all-industry average.

Demand is non-discretionary, the service radius is local, and licensing keeps the competitive field narrow. Payer mix drives the economics, and credentialing does not transfer automatically, so a gap at closing can interrupt collections for months.

Multiple
2.22x
Avg: 3.00x
Margin
74%
Avg: 19%
Default Rate
2.8%
All industries: 5.1%

Combined with a deal that performs well on the fundamentals, this is the profile lenders like to fund.

Strengths and Risks

✓ What Works

  • Strong DSCR of 2.95x clears the 2.0x Bulletproof minimum
  • Fair pricing at 2.22x earnings
  • Strong post-debt cash flow of $890,942 per year
  • Survives a 20% revenue decline stress test

⚠ Watch Out For

  • Key-person risk: verify the current owner's role in daily operations
  • Lease terms and renewal risk
  • Margin of 74% is 3.8x the 19% industry average. Verify whether a market-rate manager salary sits in the expense base. If the owner is the labor, SDE is overstated and every figure below it moves.

Who This Deal Is For

Best fit for:

Owner-operators with industry experience or management background who want a business that cash flows from day one.

First-time buyers looking for a straightforward acquisition with solid fundamentals.

Get the free 5-Day Bulletproof Buyer Crash Course
What a lender actually checks before they say yes. One email a day for five days. No fluff.
Free. Unsubscribe any time.
9.8 / 10
Bulletproof Verdict
This deal scores 9.8 out of 10 on the Bulletproof standard. The entered DSCR of 2.95x is above the 2.0x Bulletproof threshold. Operational risks should be validated in due diligence.

You read the whole analysis. Now get the listing.

Starter members see the original listing for this deal (and every Deal Review), plus new deals each week before they are gone.

Unlock Starter at $19/month → Browse more Deal Reviews →

Frequently Asked Questions

Is $3M a fair price for a healthcare / medical business?

At 2.22x seller's discretionary earnings, this asking price is within the 3.00x Bulletproof threshold and below the 3.00x benchmark for healthcare / medical businesses. The Bulletproof threshold and the category benchmark are two different yardsticks, and this deal sits inside the stricter of the two.

What is a good profit margin for a healthcare / medical business?

The benchmark profit margin for healthcare / medical businesses is approximately 19%. This listing operates at a 74% margin, which is well above the 19% benchmark for healthcare / medical businesses, about 3.9x the category figure. That is a comparison against category medians, not a verdict on this listing.

Can I buy a healthcare / medical business with an SBA loan?

Yes. Healthcare / Medical businesses are commonly financed through SBA 7(a) loans using an 80/10/10 structure: 80% SBA loan, 10% seller financing, and 10% buyer down payment. For this $3M deal the down payment is $299,900, but cash required at closing is $596,308 once closing costs and a working capital reserve of $206,438 are counted. SBA lenders require a minimum DSCR of 1.25x, but conservative buyers target 2.0x or higher. This deal's 2.95x DSCR comfortably clears both thresholds.

How much do healthcare / medical business owners actually make?

Owner earnings vary widely based on revenue, pricing, and operational involvement. This healthcare / medical business generates $1.3M in seller's discretionary earnings (SDE) before debt service. After SBA financing under the 80/10/10 structure, the buyer would take home approximately $890,942 per year. That post-debt figure is the number that actually matters for a financed acquisition, because it reflects what ends up in your pocket after every loan payment is made.